Yanlu Ying
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yanlu Ying has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anthony D. Umpierre
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
2 shared publications - Long-Jun Wu
Center for Neuroimmunology and Glial Biology, Institute of Molecular Medicine, University of Texas Health Science Center at Houston , Houston, TX 77030
2 shared publications - Yong Liu
Laboratory for Neuroimmunology in Health and Disease, Center for Medical Research On Innovation and Translation, Institute of Clinical Medicine, Department of Neurology, The Second Affiliated Hospital, South China University of Technology, Guangzhou, China
2 shared publications - Aastha Dheer
Department of Neurobiology, DIPAS, DRDO, Lucknow Road, Timarpur, New Delhi 110054, India
1 shared publication - Dale B. Bosco
Mayo Clinic
1 shared publication - Hailong Dong
Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China
1 shared publication
Latest Publications
- Open Access
Optogenetic activation of spinal microglia triggers chronic pain in mice
Spinal microglia are highly responsive to peripheral nerve injury and are known to be a key player in neuropathic pain. However, there has not been any direct evidence showing selective microglial activation in vivo is sufficient to induce chronic pain. Here we used optogenetic approaches in microglia to address this question employing CX3CR1 creER/+ : R26 LSL-ReaChR/+ transgenic mice, in which red-activated channelrhodopsin (ReaChR) is inducibly and specifically expressed in microglia. We found that activation of ReaChR by red light in spinal microglia evoked reliable inward currents and membrane depolarization. In vivo optogenetic activation of microglial ReaChR in the spinal cord triggered chronic pain hypersensitivity lasting for 5-7 days. In addition, activation of microglial ReaChR upregulated neuronal c-fos expression and enhanced C-fiber responses. Mechanistically, ReaChR activation led to a reactive microglial phenotype with increased IL-1β production. IL-1 receptor antagonist was able to reverse the pain hypersensitivity and neuronal hyperactivity induced by microglial ReaChR activation. Therefore, our work demonstrates that optogenetic activation of spinal microglia is sufficient to trigger chronic pain phenotypes by increasing neuronal activity via IL-1 signaling.
Open AccessOptogenetic activation of spinal microglia triggers chronic pain in mice
Spinal microglia are highly responsive to peripheral nerve injury and are known to be a key player in neuropathic pain. However, there has not been any direct evidence showing selective microglial activation in vivo is sufficient to induce chronic pain. Here we used optogenetic approaches in microglia to address this question employing CX3CR1 creER/+ : R26 LSL-ReaChR/+ transgenic mice, in which red-activated channelrhodopsin (ReaChR) is inducibly and specifically expressed in microglia. We found that activation of ReaChR by red light in spinal microglia evoked reliable inward currents and membrane depolarization. In vivo optogenetic activation of microglial ReaChR in the spinal cord triggered chronic pain hypersensitivity lasting for 5-7 days. In addition, activation of microglial ReaChR upregulated neuronal c-fos expression and enhanced C-fiber responses. Mechanistically, ReaChR activation led to a reactive microglial phenotype with increased IL-1β production. IL-1 receptor antagonist was able to reverse the pain hypersensitivity and neuronal hyperactivity induced by microglial ReaChR activation. Therefore, our work demonstrates that optogenetic activation of spinal microglia is sufficient to trigger chronic pain phenotypes by increasing neuronal activity via IL-1 signaling.
- Open Access
- 16 December 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
Microglial Calcium Signaling is Attuned to Neuronal Activity
Microglial calcium signaling underlies a number of key physiological processesin situ, but has not been studiedin vivoin an awake animal where neuronal function is preserved. Using multiple GCaMP6 variants targeted to microglia, we assessed how microglial calcium signaling responds to alterations in neuronal activity across a wide physiological range. We find that only a small subset of microglial somata and processes exhibited spontaneous calcium transients. However, hyperactive and hypoactive shifts in neuronal activity trigger increased microglial process calcium signaling, often concomitant with process extension. On the other hand, changes in somatic calcium activity are only observed days after severe seizures. Our work reveals that microglia have highly distinct microdomain signaling, and that processes specifically respond to bi-directional shifts in neuronal activity through calcium signaling.
- 16 December 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
Open AccessMicroglial Calcium Signaling is Attuned to Neuronal Activity
Microglial calcium signaling underlies a number of key physiological processesin situ, but has not been studiedin vivoin an awake animal where neuronal function is preserved. Using multiple GCaMP6 variants targeted to microglia, we assessed how microglial calcium signaling responds to alterations in neuronal activity across a wide physiological range. We find that only a small subset of microglial somata and processes exhibited spontaneous calcium transients. However, hyperactive and hypoactive shifts in neuronal activity trigger increased microglial process calcium signaling, often concomitant with process extension. On the other hand, changes in somatic calcium activity are only observed days after severe seizures. Our work reveals that microglia have highly distinct microdomain signaling, and that processes specifically respond to bi-directional shifts in neuronal activity through calcium signaling.